Uromigos Live 2023: Amanda Nizam on Her Proposed Trial for Patients With Oligometastatic UC
At the 2023 Uromigos Live & Unplugged event, Amanda Nizam, MD, Cleveland Clinic, discussed her proposed pilot trial during the Rising Stars panel examining enfortumab vedotin and pembrolizumab in patients with oligometastatic urothelial cancer.
630 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.